Cite
Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences.
MLA
Liblik, Kiera, et al. “Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences.” Urology, vol. 187, May 2024, pp. 114–18. EBSCOhost, https://doi.org/10.1016/j.urology.2024.02.035.
APA
Liblik, K., Caterini, J., & Touma, N. J. (2024). Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences. Urology, 187, 114–118. https://doi.org/10.1016/j.urology.2024.02.035
Chicago
Liblik, Kiera, Jessica Caterini, and Naji J. Touma. 2024. “Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences.” Urology 187 (May): 114–18. doi:10.1016/j.urology.2024.02.035.